Thomas A. Engler

2.2k citations

64 papers · 1.6k indexed · h-index 24

Impact in

Toxicology top 1%
- Bioactive Compounds and Antitumor Agents
Organic Chemistry top 2%
- Asymmetric Synthesis and Catalysis
- Oxidative Organic Chemistry Reactions
- Synthetic Organic Chemistry Methods
- Catalytic C–H Functionalization Methods
- Cyclopropane Reaction Mechanisms

Papers in

Toxicology 13
- Bioactive Compounds and Antitumor Agents 13
Organic Chemistry 39
- Asymmetric Synthesis and Catalysis 12
- Oxidative Organic Chemistry Reactions 11
- Organic Chemistry Cycloaddition Reactions 9
- Synthetic Organic Chemistry Methods 6

Co-authors: Jayachandra P. Reddy Michael A. Letavic Wenying Chai Keith D. Combrink Rajesh Iyengar E. J. Corey Fusao Takusagawa David Vander Velde
Journals: The Journal of Organic Chemistry (20 papers)Tetrahedron Letters (17 papers)Journal of the American Chemical Society (3 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Molecular Cancer Therapeutics (1 paper)
Partner nations: United States Australia Germany

In The Last Decade

Thomas A. Engler

62 papers receiving 1.5k citations

Peers

Countries citing papers authored by Thomas A. Engler

Since Specialization

Citations

This map shows the geographic impact of Thomas A. Engler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas A. Engler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas A. Engler more than expected).

Fields of papers citing papers by Thomas A. Engler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas A. Engler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas A. Engler. The network helps show where Thomas A. Engler may publish in the future.

Co-authors

The 25 scholars most cited alongside Thomas A. Engler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas A. Engler Line = papers co-authored together Thomas A. Engler links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Chemical Proteomic Characterization of a Covalent KRASG12C Inhibitor ACS Medicinal Chemistry Letters ·Aruna Wijeratne, Junpeng Xiao, Yue Mei Li, Kelly Furness, Vera G M Sistenich, Mohammad Zia‐Ebrahimi, Ana Marta Hernández García, John Strelow, Robert D. Van Horn, Sheng-Bin Peng, David A. Barda, Thomas A. Engler, Michael J. Chalmers	2018	14
2	Substitution of blood coagulation factor X-binding to Ad5 by position-specific PEGylation: Preventing vector clearance and preserving infectivity Journal of Controlled Release ·Lea Krutzke, J. Harvey, Thomas A. Engler, Christoph Q. Schmidt, Evgeny Karyagin, Andrew P. Byrnes, Thomas Simmet, Florian Kreppel	2016	31
3	Activating the Wnt/β-Catenin Pathway for the Treatment of Melanoma – Application of LY2090314, a Novel Selective Inhibitor of Glycogen Synthase Kinase-3 PLoS ONE ·Jennifer M. Atkinson, Kenneth B. Rank, Yi Arial Zeng, Andrew Capen, Vipin Yadav, Jason R. Manro, Thomas A. Engler, Márcio F. Chedid	2015	91
4	A Robust High-Content Imaging Approach for Probing the Mechanism of Action and Phenotypic Outcomes of Cell-Cycle Modulators Molecular Cancer Therapeutics ·Jeffrey J. Sutherland, Jonathan Low, Wayne Blosser, Michele Dowless, Thomas A. Engler, Louis F. Stancato	2011	26
5	Changes in Osteoblast, Chondrocyte, and Adipocyte Lineages Mediate the Bone Anabolic Actions of PTH and Small Molecule GSK‐3 Inhibitor Journal of Cellular Biochemistry ·Nalini H. Kulkarni, Tao Wei, Xiao Xian Huan, Ernst R. Dow, Trent R. Stewart, Jianyong Shou, 香櫻里北, Xingxing Mao, Bruce D. Gitter, Richard E. Higgs, David L. Halladay, Thomas A. Engler, T. John Martin, Henry U. Bryant, Yanfei Li, Jude E. Onyia	2007	54
6	Synthesis of 1,7-annulated indoles and their applications in the studies of cyclin dependent kinase inhibitors Bioorganic & Medicinal Chemistry Letters ·Guoxin Zhu, Scott E. Conner, Xun Zhou, Hak‐Kim Chan, Chuan Shih, Thomas A. Engler, Rima Al‐awar, Harold B. Brooks, Scott A. Watkins, Charles D. Spencer, Richard M. Schultz, Jack Dempsey, Eileen L. Considine, W.I Sánchez, Marjorie Montenegro, Ingrid Paola Vargas Montero, Gerrie Hughes	2004	36
7	Novel, Potent and Selective Cyclin D1/CDK4 Inhibitors: Indolo[6,7‐a]pyrrolo[3,4‐c]carbazoles. ChemInform ·Thomas A. Engler, (unknown)	2003	1
8	Lewis Acid-Promoted Reactions of 3-Methoxy-N-(benzenesulfonyl)-1,4-benzoquinone Monoimine with Propenylbenzenes The Journal of Organic Chemistry ·Thomas A. Engler, Arş. Gör. Murat Altun	1998	12
9	Tandem 5 + 2/3 + 2 and 5 + 2/3 + 3 Cycloaddition Reactions The Journal of Organic Chemistry ·Thomas A. Engler, Arş. Gör. Murat Altun, Rajesh Iyengar	1997	15
10	Stereoselective syntheses of substituted pterocarpans with anti-HIV activity, and 5-aza-/5-thia-pterocarpan and 2-aryl-2,3-dihydrobenzofuran analogues Bioorganic & Medicinal Chemistry ·Thomas A. Engler, Giullio César Mallen Silva, Rajesh Iyengar, Wenying Chai, Konstantinos A. Agrios	1996	95
11	Studies on the Synthesis of Acanthodoral and Nanaimoal: Evaluation of Cationic Cyclization Routes The Journal of Organic Chemistry ·Thomas A. Engler, Mohammed Hashmat Ali, Fusao Takusagawa	1996	7
12	Measuring Skin While Drilling Proceedings of SPE Production Operations Symposium ·Thomas A. Engler, Samuel Osisanya, Djebbar Tiab	1995	2
13	Stereospecific Lewis Acid-Promoted Reactions of Styrenyl Systems with 2-Alkoxy-(6-Alkyl)-1,4-Benzoquinones: Scope, Limitations, and Synthetic Applications The Journal of Organic Chemistry ·Thomas A. Engler, Keith D. Combrink, Michael A. Letavic, R. Jazczack, James E. Ray	1994	48
14	Stereoselective syntheses of three different classes of neolignans from the same starting materials Tetrahedron Letters ·Thomas A. Engler, Dong Wei, Michael A. Letavic	1993	11
15	Synthetic pterocarpans with anti-HIV activity Bioorganic & Medicinal Chemistry Letters ·Thomas A. Engler, R. Jazczack, Jayachandra P. Reddy, Pei-lei Ye	1993	44
16	Asymmetric induction in reactions of styrenes with 1,4-benzoquinones utilizing chiral titanium(IV) complexes Journal of the American Chemical Society ·Thomas A. Engler, Michael A. Letavic, Jayachandra P. Reddy	1991	67
17	ChemInform Abstract: Asymmetric Induction in Reactions of Styrenes with 1,4‐Benzoquinones Utilizing Chiral Ti(IV) Complexes. ChemInform ·Thomas A. Engler, Michael A. Letavic, 鄭浩柄	1991	1
18	Formal 2 + 2 and 3 + 2 cycloaddition reactions of 2H-chromenes with 2-alkoxy-1,4-benzoquinones: regioselective synthesis of substituted pterocarpans The Journal of Organic Chemistry ·Thomas A. Engler, Jayachandra P. Reddy, Keith D. Combrink, David Vander Velde	1990	48
19	A facile, stereoselective preparation of ()-2,4-pentadienoates by favorskii rearrangement Tetrahedron Letters ·Thomas A. Engler, Jörg Zimmer	1986	3
20	Methods for stereospecific synthesis of or hydrindanones Tetrahedron Letters ·E. J. Corey, Thomas A. Engler	1984	34

About Thomas A. Engler

Thomas A. Engler is a scholar working on Toxicology, Organic Chemistry, Pharmaceutical Science, Biochemistry and Cancer Research, having authored 64 papers that have together received 1.6k indexed citations. Recurring topics across this work include Bioactive Compounds and Antitumor Agents (13 papers), Asymmetric Synthesis and Catalysis (12 papers), Oxidative Organic Chemistry Reactions (11 papers), Organic Chemistry Cycloaddition Reactions (9 papers), Synthetic Organic Chemistry Methods (6 papers), Natural product bioactivities and synthesis (5 papers), Synthesis and Biological Activity (5 papers) and Fluorine in Organic Chemistry (5 papers). The work is most often cited by research in Toxicology (137 citations), Organic Chemistry (950 citations), Biochemistry (111 citations), Pharmacology (217 citations) and Biotechnology (92 citations). Thomas A. Engler has collaborated with scholars based in United States, Australia and Germany. Frequent co-authors include Jayachandra P. Reddy, Michael A. Letavic, Wenying Chai, Keith D. Combrink, Rajesh Iyengar, E. J. Corey, Fusao Takusagawa, David Vander Velde, Jutta Wanner and Manoj C. Desai. Their work appears in journals such as The Journal of Organic Chemistry, Tetrahedron Letters, Journal of the American Chemical Society, Bioorganic & Medicinal Chemistry Letters and Molecular Cancer Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact